Traws Pharma
TRAW | NASDAQ
$0.48
-$0.04 (-7.69%)
At close: Oct 7, 2026, 4:00 PM ET
-7.69%
(1D)Rating
Key Statistics
Market Data
Market Cap $7.29M
1D Range
0.47 0.52
52W Range
0.43 3.27
Valuation (TTM)
PE -0.96
PB -1.37
EV/EBITDA -0.29
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target $1.00
Cash Flow
FCF Yield -73.1%
SBC Adj. FCF Yield -86.3%
SBC Impact -18.0%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y -85.8% |
-69.4%
Dil EPS 3Y | 5Y 78.3% |
97.9%
FCF 3Y | 5Y 16.8% |
4.6%
Returns
ROA -128.7%
ROE 353.4%
ROIC 283.3%
Financial Health
Net Cash
$3.13M
Current Ratio 0.43
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Traws Pharma, Inc., a biopharmaceutical firm in the clinical development stage, is dedicated to creating novel small-molecule medications delivered orally to combat both respiratory viral infections a...
Sector Healthcare
Industry Biotechnology
Employees 7
IPO Date Jul 25, 2013
Website www.trawspharma.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
2
Consensus
Hold
Price Target
$1.00
Upside
+108.33%
Buy (0)
Hold (2)
Sell (0)
Add to Watchlist
Select watchlists to add or remove TRAW